Trial
NCT01794000
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
Daiichi Sankyo
Condition
Sickle Cell Disease
Intervention
Prasugrel
Why stopped
The study is being terminated for lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-25